July 24 (Bloomberg) -- Scientists are preparing a study on treating HIV in the earliest stage of infection, a bid to keep patients healthy that may also spur use of drugs made by GlaxoSmithKline Plc and Gilead Sciences Inc.
Read More...
[Source: Yahoo! News Search Results for liver disease help]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment